medical devices Archives - Page 3 of 7

Can Microsure turn MUSA-3’s CE mark into real hospital adoption in Europe?

Microsure has European clearance for MUSA-3. Now hospitals must decide whether robotic microsurgery can justify adoption.

Wearable CGMs dominate diabetes care. Glucotrack’s implantable CBGM now faces the harder FDA test: durable blood-based proof.

Bladder testing needs better real-world data. Bright Uro’s FDA-cleared sensor may push urodynamics beyond catheter-heavy workflows.

Heart failure care needs faster decongestion without kidney harm. Reprieve’s FASTR data now face the pivotal trial test.

TriSalus has a delivery thesis, not just a device story. PREDICTT will test whether PEDD can make Y90 liver tumor therapy more precise.

Breast cancer surgery still struggles with missed margins. Cairn Surgical’s trial raises a sharper question for wire localization.

Pancreatic cancer needs local precision. Vector Science is betting a catheter patent can move drug delivery closer to the tumor.

Retina drugs are improving, but delivery remains the bottleneck. Everads Therapy is testing whether suprachoroidal access can change that.

Neurosurgery needs precision beyond elite hospitals. ZETA SURGICAL’s FDA clearance puts AI-guided access to the real-world test.

Olympus cleared a new POWERSEAL device, but adoption now depends on surgeon trust, hospital value reviews, and open surgery workflow gains.